To further determine if combinatorial treatment caused inhibition of intracellular signaling cascade in vivo, we examined tumor samples from treated animals using western blot assay to evaluate the degree to which MAPK or AKT signaling was inhibited. The gene discussed is AKT1; the disease is neoplasm.